Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
August 6, 2007
- Astellas, Pfizer Initiate Campaign on Prevention of Arteriosclerosis
August 6, 2007
- Use IT to More Effectively Use Patients' Data: AstraZeneca President Dr Kato
August 6, 2007
- Korosho Wants to See 1/4-1/3 of World's New Drugs Developed in Japan: New Industry Vision
August 6, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 6, 2007
- BUSINESS NEWS IN BRIEF
August 6, 2007
- New Nycomed to Go Global through Partnering
August 6, 2007
- Makers' Accountability Essential to Implement JPMA's Proposal: FPMAJ President
August 6, 2007
- Exelon Skin Patch Recommended for European Approval: Novartis
August 6, 2007
- 11 Generic Products (6 APIs) to Be Listed in November
July 30, 2007
- SELF-MEDICATION NEWS IN BRIEF
July 30, 2007
- NPhA to Further Promote Use of Generics
July 30, 2007
- OPINION／Once in a Lifetime
July 30, 2007
- MD Studies to Be Permitted at a Total Dose of 500 μg: Dr Ohno
July 30, 2007
- TOPICS／Mebix Starts Home Blood Pressure Management Service
July 30, 2007
- RIKEN, Harvard Univ. Hospital Decipher Protein Structure of LTC4 Synthase
July 30, 2007
- Nutrition Management Improves QOL, Reduces Costs: Prof. Ohyanagi
July 30, 2007
- NanoCarrier Obtains Patent on Macromolecular Micelles
July 30, 2007
- Adiponectin Stimulates Appetite in the Brain: Prof. Kadowaki
July 30, 2007
- R&D NEWS IN BRIEF(1)
July 30, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…